CardioTube Interview | Late Breaking Clinical Science | Supra-annular Vs. Intra-annular Devices For Tavr-in-tavr: The Pandora International Registry

Sunday, March 9, 2025

8:45 AM – 9:00 AM ET

Interviewer(s)

Steven J. Yakubov, MD, FACC, MSCAI

System/Medical Chief - Structural Heart Disease
OhioHealth/Riverside Methodist Hospital
Columbus, Ohio, United States

Disclosure(s): BioStar: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Interviewee(s)

Luca Testa, MD, PhD, Professor of Cardiology

Head of Coronary Revascularization Unit; Head of Clinical Research Unit
IRCCS Pol. S. Donato, Milan, Italy
Roma, Lazio, Italy

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Steven J. Yakubov, MD, FACC, MSCAI: BioStar: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Luca Testa, MD, PhD, Professor of Cardiology: No financial relationships to disclose